Ariela Noy

25PUBLICATIONS
168CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Mar 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Matthew Hamby, Brian L Egleston, Zachary A K Frosch

|Nov 19, 2025
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Matthew Hamby, Brian Egleston, Zachary Frosch

|Aug 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era.

Giulio Cassanello, Esther Drill, Annie Qiu

|Jul 17, 2025
Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.

Raphael Steiner, Liana Nikolaenko, Ranjit Nair

Pageof 5

Frequent Collaborators

10 joint publications

Ahmet Dogan

9 joint publications

Gilles Salles

8 joint publications

Andrew D Zelenetz

7 joint publications

Matthew Matasar